<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116460">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01587053</url>
  </required_header>
  <id_info>
    <org_study_id>8745</org_study_id>
    <nct_id>NCT01587053</nct_id>
  </id_info>
  <brief_title>Anti Vitamin K Therapeutic Education</brief_title>
  <official_title>Anti Vitamin K Therapeutic Education With INR Self Measure Device Within Children From 0 to 18 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the INR (International Normalized Ratio) time
      percentage in the target zone (TTR: time in therapeutic range) of children benefiting from
      the AVK therapeutic education program.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty recruiting
  </why_stopped>
  <start_date type="Actual">April 2012</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>INR (International Normalized Ratio) time percentage in the target zone (TTR: time in therapeutic range)</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">57</enrollment>
  <condition>Cardio-vascular Diseases</condition>
  <arm_group>
    <arm_group_label>AVK</arm_group_label>
    <description>patient with AVK treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>therapeutic education program</intervention_name>
    <arm_group_label>AVK</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        children from 0 to 18 years having AVK prescription
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age from 0 to 18 years

          -  AVK prescription

          -  to accept participating to AVK therapeutic education program

          -  informed consent form of parents or legal person

        Exclusion Criteria:

          -  parents or legal person refusal to enter in the AVK therapeutic education
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal AMEDRO, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatric and Congénital Cardiology Department, UH Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pediatric and Congénital Cardiology Department</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 6, 2017</lastchanged_date>
  <firstreceived_date>April 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin K</mesh_term>
    <mesh_term>Antivitamins K</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
